We are live on ! Find out more
PRDS

Pardes Biosciences, Inc. Common Stock

Delisted

PRDS was delisted on the 30th of August, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$16.7M -$424K -42,222 -2%
ACA
2
Arena Capital Advisors
California
$15.1M +$11.9M +1,182,588 +358%
FCM
3
Farallon Capital Management
California
$10M
PHS
4
PFM Health Sciences
California
$10M
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$9.98M
JCM
6
JS Capital Management
New York
$9.98M
RCM
7
RA Capital Management
Massachusetts
$9.98M
SRCM
8
Sage Rock Capital Management
New York
$8.24M
FCMV
9
Foresite Capital Management V
California
$6.01M
MAMNY
10
Marathon Asset Management (New York)
New York
$5.79M
Millennium Management
11
Millennium Management
New York
$5.21M +$477K +47,503 +10%
C
12
Chescapmanager
Maryland
$4.88M
Citadel Advisors
13
Citadel Advisors
Florida
$4.74M -$2.48M -247,455 -34%
GCL
14
Glazer Capital LLC
New York
$4.58M -$4.35M -433,744 -49%
Alyeska Investment Group
15
Alyeska Investment Group
Illinois
$4.49M
Franklin Resources
16
Franklin Resources
California
$4M
HMC
17
Harvard Management Company
Massachusetts
$4M
SCM
18
Suvretta Capital Management
New York
$3.99M
DCM
19
DAFNA Capital Management
California
$2.99M
SC
20
Sculptor Capital
New York
$2.42M +$723K +72,000 +42%
RSCM
21
Rock Springs Capital Management
Maryland
$2.09M
WP
22
Woodline Partners
California
$2.07M
6CM
23
683 Capital Management
New York
$2M +$2.01M +200,288 New
ACM
24
Altium Capital Management
New York
$2M
BCM
25
BlueCrest Capital Management
Jersey
$1.5M